04/25/2024 4:24 PM | Structure Therapeutics (Filer)
| Form ARS | |
04/19/2024 1:13 PM | FMR LLC (Reporting) Structure Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/20/2024 6:34 PM | Stevens Raymond C (Reporting) Structure Therapeutics (Issuer)
| Form 4/A | |
03/20/2024 6:37 PM | Structure Therapeutics (Issuer) Yoon Jun (Reporting)
| Form 4/A | |
03/20/2024 6:39 PM | Ma Yingli (Reporting) Structure Therapeutics (Issuer)
| Form 4/A | |
03/20/2024 6:41 PM | Bach Mark Allen (Reporting) Structure Therapeutics (Issuer)
| Form 4/A | |
03/20/2024 6:42 PM | Lin Xichen (Reporting) Structure Therapeutics (Issuer)
| Form 4/A | |
|
03/19/2024 3:36 PM | Stevens Raymond C (Reporting) Structure Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/18/2024 7:52 AM | FMR LLC (Reporting) Structure Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/08/2024 3:19 PM | Structure Therapeutics (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/08/2024 8:19 AM | Structure Therapeutics (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
03/08/2024 7:43 AM | Structure Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/15/2024 10:11 AM | FMR LLC (Reporting) Structure Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2024 8:07 AM | Avoro Capital Advisors LLC (Filed by) Structure Therapeutics (Subject)
| Form SC 13G | |
02/14/2024 7:45 AM | Deep Track Capital, LP (Filed by) Structure Therapeutics (Subject)
| Form SC 13G/A | |
02/09/2024 8:49 AM | FMR LLC (Filed by) Structure Therapeutics (Subject)
| Form SC 13G/A | |
02/09/2024 6:59 AM | FIL Ltd (Filed by) Structure Therapeutics (Subject)
| Form SC 13G/A | |
02/06/2024 10:01 AM | Structure Therapeutics (Subject) WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G/A | |
12/27/2023 9:49 AM | Structure Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/27/2023 9:49 AM | FMR LLC (Reporting) FMR LLC (Reporting) Structure Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/20/2023 3:36 PM | BIOTECHNOLOGY VALUE FUND L P (Filed by) Structure Therapeutics (Subject)
| Form SC 13G/A | |
12/18/2023 7:28 AM | Structure Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/07/2023 10:04 AM | FMR LLC (Reporting) Structure Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/29/2023 11:15 PM | Structure Therapeutics (Filer)
| Form EFFECT | |
11/17/2023 4:25 PM | Structure Therapeutics (Filer)
| Form S-1 Registration statement under Securities Act of 1933 | |
11/17/2023 3:51 PM | Structure Therapeutics (Filer)
| Form 10-Q/A | |
11/17/2023 3:55 PM | Structure Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
11/16/2023 4:13 PM | Structure Therapeutics (Filer)
| Form 10-Q/A | |
10/23/2023 2:55 PM | FMR LLC (Reporting) Structure Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/13/2023 3:00 PM | FMR LLC (Filed by) Structure Therapeutics (Subject)
| Form SC 13G/A | |
10/12/2023 7:55 AM | FMR LLC (Reporting) Structure Therapeutics (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
10/04/2023 11:01 AM | FIL Ltd (Filed by) Structure Therapeutics (Subject)
| Form SC 13G/A | |
09/29/2023 6:50 AM | Structure Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/29/2023 6:38 AM | Structure Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/04/2023 4:37 PM | Structure Therapeutics (Issuer) WELCH DANIEL G (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/04/2023 4:29 PM | LOVE TED W (Reporting) Structure Therapeutics (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
08/04/2023 4:34 PM | LOVE TED W (Reporting) Structure Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/04/2023 3:30 PM | Structure Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/12/2023 7:00 PM | BIOTECHNOLOGY VALUE FUND II LP (Reporting) BIOTECHNOLOGY VALUE FUND L P (Reporting) Biotechnology Value Trading Fund OS LP (Reporting) BVF GP HOLDINGS LLC (Reporting) BVF I GP LLC (Reporting) BVF II GP LLC (Reporting) BVF INC/IL (Reporting) BVF PARTNERS L P/IL (Reporting) BVF Partners OS Ltd. (Reporting) LAMPERT MARK N (Reporting) Structure Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/11/2023 4:00 PM | Structure Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |